Refractory B-Cell Non-Hodgkin Lymphoma

Showing 26 - 32 of 32

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Seattle (procedure,

Completed
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 29, 2020

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent T-Cell Non-Hodgkin Lymphoma Trial in Seattle

Terminated
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +5 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 26, 2020

CD19 Positive, Mantle Cell Lymphoma, Recurrent DLBCL Trial in Houston (procedure, drug, biological)

Withdrawn
  • CD19 Positive
  • +6 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2020

Relapsed B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in Worldwide (AFM11)

Terminated
  • Relapsed B-Cell Non-Hodgkin Lymphoma
  • Refractory B-Cell Non-Hodgkin Lymphoma
  • Boston, Massachusetts
  • +8 more
Jun 17, 2019

CD20 Positive, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (Ipilimumab,

Completed
  • CD20 Positive
  • +2 more
  • Ipilimumab
  • +2 more
  • Duarte, California
  • +6 more
Apr 10, 2018

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Indolent Adult Non-Hodgkin Lymphoma

Completed
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +3 more
  • Portland, Oregon
  • +1 more
Nov 9, 2017

Relapsed/Refractory Aggressive Non Hodgkin Lymphoma Treated With

Completed
  • Refractory B-Cell Non-Hodgkin Lymphoma
  • Recurrent B-Cell Non-Hodgkin Lymphoma
    • (no location specified)
    Dec 12, 2016